Last reviewed · How we verify

NCT05089422

Study of Clinical Types and Surgical Out Come of Pediatric Exotropia

Status unknown NA Last updated 22 October 2021
What this trial tests

NA trial testing Squint surgery in Exotropia in 30 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
31 January 2022
30 July 2022

Quick facts

Lead sponsorSohag University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment30
Start date1 November 2021
Primary completion31 January 2022
Estimated completion30 July 2022

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Under 15, any sex, with Exotropia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

study aiming to evaluate all children presented to strabismus clinic in ophthalmology department at sohag university hospital with divergent squint (exotropia) and to record surgical outcome of those who underwent strabismus surgery in our hospital

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Exotropia

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05089422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing